Zepp Health (NYSE:ZEPP) Given a $14.65 Price Target by Fundamental Research Analysts

Fundamental Research set a $14.65 target price on Zepp Health (NYSE:ZEPP) in a research report released on Tuesday morning,BayStreet.CA reports. The brokerage currently has a buy rating on the stock.

Zepp Health Trading Up 4.2 %

NYSE:ZEPP opened at $2.96 on Tuesday. Zepp Health has a one year low of $2.06 and a one year high of $8.40. The company has a market cap of $44.55 million, a PE ratio of -1.18 and a beta of 0.68. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.21 and a quick ratio of 0.87. The firm has a 50-day moving average of $3.36 and a 200-day moving average of $3.00.

Institutional Investors Weigh In On Zepp Health

A hedge fund recently bought a new stake in Zepp Health stock. Virtu Financial LLC bought a new position in shares of Zepp Health Co. (NYSE:ZEPP) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 13,056 shares of the company’s stock, valued at approximately $57,000. Virtu Financial LLC owned approximately 0.09% of Zepp Health as of its most recent SEC filing. 52.61% of the stock is owned by hedge funds and other institutional investors.

Zepp Health Company Profile

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.